Quick Answer
Prime Medicine, Inc. reported Net Income of -$201.14 million for fiscal year 2025.
Prime Medicine, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$201.14M | -2.7% |
| 2024 | -$195.88M | +1.1% |
| 2023 | -$198.13M | -62.6% |
| 2022 | -$121.82M | +26.3% |
| 2021 | -$165.37M | -4749.5% |
| 2020 | -$3.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$50.58M | +3.7% | +3.8% |
| June 30, 2025 | -$52.59M | +4.9% | -1.4% |
| March 31, 2025 | -$51.89M | -13.4% | +1.2% |
| September 30, 2024 | -$52.52M | -3.6% | +5.1% |
| June 30, 2024 | -$55.33M | -30.5% | -20.9% |
| March 31, 2024 | -$45.76M | -16.2% | +9.8% |
| September 30, 2023 | -$50.71M | -72.8% | -19.6% |
| June 30, 2023 | -$42.38M | -44.4% | -7.6% |
- Prime Medicine, Inc. showed a decrease of -2.7% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Prime Medicine, Inc.’s net income has declined by 5798.6% (from -$3.41 million to -$201.14 million).
- The most recent figure is from Prime Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: